Previous studies have shown that while some women who use aspirin and are later diagnosed with breast cancer may live longer, a portion of aspirin users with breast cancer appeared to have a higher risk of mortality following breast cancer. According to a new study, the reason for this reverse effect could be explained by DNA methylation of genes in breast cancer tumors or peripheral blood.